Background: Perinatal stroke includes fetal or prenatal stroke and neonatal stroke. It has been hypothesized that an abnormality in the placenta could be one of the risk factors for perinatal stroke and placental pathology could reveal a pattern of stroke. The aims of this study were to systematically review the literature to identify the role of the placenta in perinatal stroke, ascertain the prevalence of placental pathology and establish uniform terms to describe placental pathology.
Mymensingh, Bangladesh.
Uterine rupture is a deadly obstetrical emergency endangering the life of mother & foetus. The present study aims to evaluate relationship between socio-demographic backgrounds in perinatal outcome of rupture uterus cases. It is a descriptive cross sectional study 1 year period (January to December 2013) performed in Mymensingh Medical College Hospital, Mymensingh, Bangladesh. Rupture uterus cases who were received & did not die within 30 minutes of admission and was included in this study. Analysis was done by Microsoft Excel. Result showed 72 cases of uterine rupture out of 5484 deliveries including 3619 caesarean sections with an incidence of 1:83. From rural areas 87.5% case where facilities not available, poor socio-economic condition were 79%, peak age between 20-30 years (68%), 56% were illiterate, 46% cases had no antenatal check-up, 66.67% were exposed to injudicious use of oxytocic agents before admission, 38.9% handled by untrained birth attendant. Among 72 babies 12.5% were asphyxiated, 87.5% cases still born babies were found. Method: Eligible studies were identified by searching the PubMed database for all articles published prior to November 30th, 2016, and by reviewing the reference lists of retrieved articles.
Results: Twenty-two full text articles were identified, of which nine (total 194 preterm and term infants) were included in the review: two randomised controlled trials (RCTs), four prospective observational studies, one retrospective study, and two case reports. One RCT allocated infants <1500 g failing CPAP to either biphasic positive airway pressure or nHFOV and reported a treatment failure rate of 65% compared with 38% favouring nHFOV (p = 0.09); the other showed a significant reduction in treatment time for transient tachypnoea when nHFOV was compared with CPAP (105 vs 377 minutes, p < 0.0001).
Conclusions: Current evidence suggests that nHFOV may be a promising alternative to other non-invasive modes in terms of supporting alveolar ventilation and preventing need for endotracheal intubation. Adequately powered RCTs are warranted to evaluate appropriate clinical indications, optimal settings and safety of nHFOV in the neonatal population. Background: Elective transfusion of red blood cells is a common therapeutic intervention for the treatment of anaemia of prematurity. However, the optimal clinical and/or haematological indications for non-urgent transfusion are unclear leading to wide variation in clinical practice.
Method: Using an anonymised online survey sent to practitioners working in Level 1-3 SCBU/NICUs in Australian and New Zealand, a sequence of hypothetical cases were designed to assess current transfusion practice, presence of individual Unit guidelines, preference for a 'restrictive' vs. 'liberal' transfusion policy (Cochrane 2011) and the use of clinical adjuncts to assist decision making.
Results: Overall 130 participants responded to at least one question. There was significant variation in the haemoglobin-based transfusion threshold (60-110 g/L). Most participants (91/103) reported that they would use multiple haematological and clinical measures to inform treatment decision-making. A 'restrictive' transfusion policy was supported by 51/102 respondents, a 'liberal' policy by 18, 20 supported neither, and 13 were unsure. 45/87 respondents thought that cerebral hypoxia detected by Near Infrared Spectroscopy may become a useful adjunct marker of clinically significant anaemia warranting transfusion.
Conclusions: Management of anaemia of prematurity varies significantly within Australasian neonatal units, and further research is required to rationalise the current transfusion guidelines. Background: The optimal transfusion threshold for anaemia of prematurity is currently unknown and duration of potential benefit unclear. The Wellington NICU transfusion policy is based on the restrictive transfusion thresholds used in the PINT study. We hypothesized that elective transfusion would lead to sustained improvement in tissue oxygenation and cardio-respiratory stability.
EFFECT OF ELECTIVE BLOOD
Method: Multiprobe Near Infrared Spectroscopy (Sensmart X-100, Nonin) was applied to 25 preterm infants receiving nonurgent blood transfusion. Cerebral, hepatic and muscle regional tissue oxygenation was studied before, during, immediately after, 1 and 5 days after transfusion. Cardio-respiratory stability was examined concurrently using pulse oximetry (Rad-7/8, Masimo) to determine Desaturation Index 4% (DI4) and time spent with SpO 2 < 90%, and Finapres (Human NIBP, ADInstruments) measurement of HR and BP.
Results: Improvement in cerebral oxygenation was seen immediately after blood transfusion (76% vs. 79% p = 0.0029) but this effect was not sustained 5 days after the transfusion (76% vs. 77%, p = 0.8). There was no significant change in hepatic or muscle oxygenation, or in DI4, time spent with SpO 2 < 90%, mean HR or mean BP at any time following transfusion.
Conclusions: Elective blood transfusion, based on the current restrictive guideline, resulted in short-term, unsustained improvement in cerebral oxygenation. Further research is required to study the role of NIRS in rationalising transfusion guidelines for anaemia of prematurity. Background: Preterm prelabour rupture of membranes (PPROM) is a common cause of preterm birth and perinatal morbidity and mortality. Infection is a well-recognised risk factor for PPROM. The Pro-PPROM trial aims to: (1) examine whether oral probiotic therapy for women with PPROM prolongs pregnancy duration; and (2) describe the maternal and neonatal microbiota after PPROM and probiotic therapy.
Methods: This study will be a multicentre double-blind, placebo-controlled, randomised controlled trial to assess probiotic administration as an adjunct to standard antibiotic treatment in women with PPROM between 24 and 34 weeks' gestation. Women randomised to treatment will have Lactobacillus fermentum CECT5716 twice daily. The primary outcome is the proportion of women undelivered at seven days following PPROM. The mean latency is 5.2 days (SD 11.9) calculated from PPROMT trial latency data. Secondary outcomes include perinatal and maternal morbidity and mortality. A sample size of 78 is required to detect a 30% increase in the number of women who remain pregnant at seven days, from 19.7% to 25.6%, with 80% power and twosided 5% significance level. The maternal and neonatal microbiota will be examined by polymerase chain reaction (PCR) of low vaginal swabs obtained during pregnancy, the placental basal plate and a neonatal meconium sample.
Discussion: This trial will provide evidence for probiotic effectiveness in prolonging pregnancy after PPROM. This pilot study will inform a larger trial to examine the effect of probiotics on perinatal outcomes in women at increased risk of preterm birth. Royal Women's Hospital, Randwick Background: Non-invasive Neurally Adjusted Ventilatory Assist (NAVA) is a mode of respiratory support that provides synchronised multilevel pressure support. Electrical diaphragmatic activity (Edi) is used to trigger synchronous breaths and proportionally assist inspiratory efforts. We have been using NAVA in our unit for the last two years for three indications: Postextubation as a weaning mode from invasive ventilation; As an escalation mode from nasal CPAP to avoid intubation; As nasal CPAP therapy with backup facility to treat apnoeas.
NON-INVASIVE
Methods: We retrospectively reviewed all cases where NAVA was used in our NICU over the last 12 months. For each of the above indications we used pre-defined criteria to determine the effectiveness of the application of NAVA in each case.
Results: There were 49 episodes of NAVA application in 33 infants (median gestation 27 weeks ) during the study period. When used post-extubation, 15 of 16 high risk infants did not require reintubation within 48 hours (1 extubation failure in context of sepsis). When used as an escalation mode
